 REHOVOT, Israel, March 26, 2021 PRNewswire -- CollPlant NASDAQ: CLGN, a regenerative and aesthetic medicine company, today announced financial results for the full year ended December 31, 2020 and provided an update on the Companys business developments. Certain metrics, including those expressed on an adjusted basis, are non-GAAP measures. 